Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study.
Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study.
复制标题
DOI:
10.1136/bmjopen-2022-066164
复制
发表时间:
2023-01-31
期刊:
影响因子:
2.9
通讯作者:
中科院分区:
文献类型:
--
作者:
To characterise factors associated with COVID-19 vaccine uptake among people with kidney disease in England. Retrospective cohort study using the OpenSAFELY-TPP platform, performed with the approval of NHS England. Individual-level routine clinical data from 24 million people across GPs in England using TPP software. Primary care data were linked directly with COVID-19 vaccine records up to 31 August 2022 and with renal replacement therapy (RRT) status via the UK Renal Registry (UKRR). A cohort of adults with stage 3–5 chronic kidney disease (CKD) or receiving RRT at the start of the COVID-19 vaccine roll-out was identified based on evidence of reduced estimated glomerular filtration rate (eGFR) or inclusion in the UKRR. Dose-specific vaccine coverage over time was determined from 1 December 2020 to 31 August 2022. Individual-level factors associated with receipt of a 3-dose or 4-dose vaccine series were explored via Cox proportional hazards models. 992 205 people with stage 3–5 CKD or receiving RRT were included. Cumulative vaccine coverage as of 31 August 2022 was 97.5%, 97.0% and 93.9% for doses 1, 2 and 3, respectively, and 81.9% for dose 4 among individuals with one or more indications for eligibility. Delayed 3-dose vaccine uptake was associated with younger age, minority ethnicity, social deprivation and severe mental illness—associations that were consistent across CKD severity subgroups, dialysis patients and kidney transplant recipients. Similar associations were observed for 4-dose uptake. Although high primary vaccine and booster dose coverage has been achieved among people with kidney disease in England, key disparities in vaccine uptake remain across clinical and demographic groups and 4-dose coverage is suboptimal. Targeted interventions are needed to identify barriers to vaccine uptake among under-vaccinated subgroups identified in the present study.
登录
查看更多内容
影响因子:
19.6
作者:
Ng, Jia H.;Hirsch, Jamie S.;Fishbane, Steven
通讯作者:
Fishbane, Steven
DOI:
10.3399/bjgp.2021.0376
发表时间:
2022-01
期刊:
The British journal of general practice : the journal of the Royal College of General Practitioners
影响因子:
--
作者:
Curtis HJ;Inglesby P;Morton CE;MacKenna B;Green A;Hulme W;Walker AJ;Morley J;Mehrkar A;Bacon S;Hickman G;Bates C;Croker R;Evans D;Ward T;Cockburn J;Davy S;Bhaskaran K;Schultze A;Rentsch CT;Williamson EJ;Rowan A;Fisher L;McDonald HI;Tomlinson L;Mathur R;Drysdale H;Eggo RM;Wing K;Wong AY;Forbes H;Parry J;Hester F;Harper S;O'Hanlon S;Eavis A;Jarvis R;Avramov D;Griffiths P;Fowles A;Parkes N;Douglas IJ;Evans SJ;Smeeth L;Goldacre B;(The OpenSAFELY Collaborative)
通讯作者:
(The OpenSAFELY Collaborative)
DOI:
10.1056/nejmoa2119451
发表时间:
2022-04-21
期刊:
The New England journal of medicine
影响因子:
--
作者:
Andrews N;Stowe J;Kirsebom F;Toffa S;Rickeard T;Gallagher E;Gower C;Kall M;Groves N;O'Connell AM;Simons D;Blomquist PB;Zaidi A;Nash S;Iwani Binti Abdul Aziz N;Thelwall S;Dabrera G;Myers R;Amirthalingam G;Gharbia S;Barrett JC;Elson R;Ladhani SN;Ferguson N;Zambon M;Campbell CNJ;Brown K;Hopkins S;Chand M;Ramsay M;Lopez Bernal J
通讯作者:
Lopez Bernal J
DOI:
10.1093/ndt/gfx280
发表时间:
2018-08-01
期刊:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
影响因子:
--
作者:
Kim LG;Cleary F;Wheeler DC;Caplin B;Nitsch D;Hull SA;UK National Chronic Kidney Disease Audit
通讯作者:
UK National Chronic Kidney Disease Audit
影响因子:
39.2
作者:
Levey AS;Stevens LA;Schmid CH;Zhang YL;Castro AF 3rd;Feldman HI;Kusek JW;Eggers P;Van Lente F;Greene T;Coresh J;CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
通讯作者:
CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)